We appreciate the comments in the letter to the editor. The letter addressed that specific KRAS mutation in non-small cell lung cancer (NSCLC) patients with brain metastases is associated with worse response to radiotherapy [1], and it might cause bias in our results from a retrospective cohort.
from Imaging via alkiviadis.1961 on Inoreader http://ift.tt/2ld5NTu
Τρίτη 26 Δεκεμβρίου 2017
Response to Stephane Renaud et al.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: Available online 8 April 2017 Source: Cortex Author(s): Jeremy Purcell, Rajani Sebastian, Richard Leigh, Samson Jarso,...
-
Prof. Murray Leibbrandt - Professor and SALDRU Director. About Books and Book Chapters Publications and Working Papers. 021 650 2726: @: 3 ...
-
OBJECTIVE: MicroRNAs (miRNAs) are epigenetic regulators of gene expression, and their deregulation plays an important role in human cancer,...
-
With a highly professional, friendly and compassionate staff, Coral Springs Funeral Home is the first choice for hundreds of area families e...
-
OBJECTIVE: This study was aimed to explore the underlying genes associated with lung cancer (LC) by bioinformatics analysis. DATA AND METH...
-
The impact of industrialised societies on Earth has been described in a mathematical formula that should scare us all, says Owen Gaffney ...
-
Astrophel' is a fanciful half-Greek anagram for the poet's own name, and Stella (Star) designates Lady Penelope Devereux, who at abo...
-
Abstract: Patients with neurofibromatosis type 1 (NF-1) have a well-known predisposition for certain types of malignancies, including lympho...
-
Biomarkers for Hearing Dysfunction: Facts and Outlook. ORL J Otorhinolaryngol Relat Spec. 2017 Feb 24;79(1-2):93-111 Authors: Rüttige...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου